WE

Weave Communications, Inc.

WEAVHealthcareNASDAQ

Health Information Services · Last scanned Jul 16, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$239.0M
+17.0% YoY
Net Income
-$28.1M
+1.0% YoY
EBITDA
-$10.8M
+3.5% YoY
Free Cash Flow
$39.8M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 88.8, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 84.3, above 70, stock may be overbought
About Weave Communications, Inc.

Weave Communications, Inc. operates an AI-powered patient communications, engagement, and payments platform for small and medium-sized healthcare businesses. With a market capitalization of $584.8M, it sits in small-cap territory. It offers AI-receptionist; Unified Phone Number; Customized Phone System, a smarter phone system to identify whether incoming calls are from new or current patients, provide information at every call, and manage heavy call times; Softphones to make and receive calls from anywhere with an internet connection; Text Messaging and SMS response assistant; Missed Call Text that allows practices to respond when a call is missed; Missed Text Auto-Reply that replies to patient text messages by automatically responding to messages received outside of a practice's normal operating hours; Team Chat, a group messaging solution; and Weave Mobile App.

Key stats
Market Cap$584.8M
Fwd P/E31.28
EPS$-0.32
Beta1.68
52W Change-0.4%
ROE-32.9%
Analysis

The balance sheet looks solid with $72.7M in cash comfortably exceeding the $51.3M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $39.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -32.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $142.1M (2022) to $239.0M (2025), reflecting a 68% increase over the period.

Weave Communications, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Weave Communications, Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms